Carbapenem-resistant Acinetobacter baumannii acquired before liver transplantation: Impact on recipient outcomes

Liver Transplantation

Volumn 22, Issue 5, 2016, Pages 615-626

  Freire, Maristela Pinheiro ^a   Pierrotti, Ligia Câmera ^a   Oshiro, Isabel Cristina Villela Soares ^a   Bonazzi, Patrícia Rodrigues ^a   Oliveira, Larissa Marques De ^a   MacHado, Anna Silva ^a   Van Der Heijden, Inneke Marie ^a   Rossi, Flavia ^a   Costa, Silvia Figueiredo ^a   D'Albuquerque, Luiz Augusto Carneiro ^a   Abdala, Edson ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; CARBAPENEM RESISTANT ACINETOBACTER BAUMANNII; CARBAPENEM RESISTANT ACINETOBACTER BAUMANNII INFECTION; COLD ISCHEMIA; DIALYSIS; FEMALE; GRAFT RECIPIENT; HEPATITIS; HUMAN; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; NONHUMAN; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RISK FACTOR; SURVEILLANCE CULTURE; ACINETOBACTER INFECTIONS; ANTIBIOTIC RESISTANCE; COMPLICATION; DRUG EFFECTS; LIVER FAILURE; MIDDLE AGED; POSTOPERATIVE COMPLICATION; PROSPECTIVE STUDY; PULSED FIELD GEL ELECTROPHORESIS; REOPERATION; TIME FACTOR; TREATMENT OUTCOME; YOUNG ADULT;

ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; CARBAPENEMS; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; HUMANS; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; REOPERATION; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84964746077     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.24389     Document Type: Article

References (29)

1. Zhong L, Men TY, Li H, Peng ZH, Gu Y, Ding X, et al., Multidrug-resistant gram-negative bacterial infections after liver transplantation-spectrum and risk factors. J Infect 2012; 64: 299-310.
2. Bodro M, Sabé N, Tubau F, Lladó L, Baliellas C, Roca J, et al., Risk factors and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in solid-organ transplant recipients. Transplantation 2013; 96: 843-849.
3. Ye QF, Zhao J, Wan QQ, Qiao BB, Zhou JD,. Frequency and clinical outcomes of ESKAPE bacteremia in solid organ transplantation and the risk factors for mortality. Transpl Infect Dis 2014; 16: 767-774.
4. van Duin D, van Delden C,; for AST Infectious Diseases Community of Practice. Multidrug-resistant gram-negative bacteria infections in solid organ transplantation. Am J Transplant 2013; 13 (suppl 4): 31-41.
5. Shi SH, Kong HS, Xu J, Zhang WJ, Jia CK, Wang WL, et al., Multidrug resistant gram-negative bacilli as predominant bacteremic pathogens in liver transplant recipients. Transpl Infect Dis 2009; 11: 405-412.
6. Kim YJ, Yoon JH, Kim SI, Hong KW, Kim JI, Choi JY, et al., High mortality associated with Acinetobacter species infection in liver transplant patients. Transplant Proc 2011; 43: 2397-2399.
7. Hsieh CE, Chen YL, Lin PY, Lin KH, Lin HC, Liu CE, et al., Liver transplantation in patients infected with gram-negative bacteria: non-Acinetobacter baumannii and Acinetobacter baumannii. Transplant Proc 2013; 45: 225-230.
8. Souli M, Galani I, Giamarellou H,. Emergence of extensively drug-resistant and pandrug-resistant gram-negative bacilli in Europe. Euro Surveill 2008; 13: 19045.
9. Shields RK, Clancy CJ, Gillis LM, Kwak EJ, Silveira FP, Massih RC, et al., Epidemiology, clinical characteristics and outcomes of extensively drug-resistant Acinetobacter baumannii infections among solid organ transplant recipients. PLoS One 2012; 7: e52349.
10. de Gouvêa EF, Martins IS, Halpern M, Ferreira AL, Basto ST, Gonçalves RT, et al., The influence of carbapenem resistance on mortality in solid organ transplant recipients with Acinetobacter baumannii infection. BMC Infect Dis 2012; 12: 351.
11. Horan TC, Andrus M, Dudeck MA,. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008; 36: 309-332.
12. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Twenty-second informational supplement. CLSI document M100-S22. Wayne, PA: CLSI; 2012.
13. Seifert H, Dolzani L, Bressan R, van der Reijden T, van Strijen B, Stefanik D, et al., Standardization and interlaboratory reproducibility assessment of pulsed-field gel electrophoresis-generated fingerprints of Acinetobacter baumannii. J Clin Microbiol 2005; 43: 4328-4335.
14. Freire MP, Soares Oshiro IC, Bonazzi PR, Guimarães T, Ramos Figueira ER, Bacchella T, et al., Surgical site infections in liver transplant recipients in the Model for End-Stage Liver Disease era: an analysis of the epidemiology, risk factors, and outcomes. Liver Transpl 2013; 19: 1011-1019.
15. Freire MP, Van Der Heijden IM, do Prado GV, Cavalcante LS, Boszczowski I, Bonazzi PR, et al., Polymyxin use as a risk factor for colonization or infection with polymyxin-resistant Acinetobacter baumannii after liver transplantation. Transpl Infect Dis 2014; 16: 369-378.
16. Weintrob AC, Roediger MP, Barber M, Summers A, Fieberg AM, Dunn J, et al., Natural history of colonization with gram-negative multidrug-resistant organisms among hospitalized patients. Infect Control Hosp Epidemiol 2010; 31: 330-337.
17. Marchaim D, Navon-Venezia S, Schwartz D, Tarabeia J, Fefer I, Schwaber MJ, Carmeli Y,. Surveillance cultures and duration of carriage of multidrug-resistant Acinetobacter baumannii. J Clin Microbiol 2007; 45: 1551-1555.
18. Dalben MF, Oliveira MS, Garcia CP, Lobo RD, Costa SF, Toscano CM, Levin AS,. Swab cultures across three different body sites among carriers of carbapenem-resistant P. aeruginosa and Acinetobacter species: a poor surveillance strategy. J Hosp Infect 2010; 74: 395-396.
19. Tacconelli E, Cataldo MA, Dancer SJ, De Angelis G, Falcone M, Frank U, et al.,; for European Society of Clinical Microbiology. ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant gram-negative bacteria in hospitalized patients. Clin Microbiol Infect 2014; 20 (suppl 1): 1-55.
20. Kim YJ, Kim SI, Jun YH, Choi JY, Yoon SK, You YK, Kim DG,. Clinical significance of surveillance culture in liver transplant recipients. Transplant Proc 2014; 46: 828-831.
21. Freire MP, Antonopoulos IM, Piovesan AC, Moura ML, de Paula FJ, Spadão F, et al., Amikacin prophylaxis and risk factors for surgical site infection after kidney transplantation. Transplantation 2015; 99: 521-527.
22. Paugam-Burtz C, Kavafyan J, Merckx P, Dahmani S, Sommacale D, Ramsay M, et al., Postreperfusion syndrome during liver transplantation for cirrhosis outcome and predictors. Liver Transpl 2009; 15: 522-529.
23. Martin EF, Huang J, Xiang Q, Klein JP, Bajaj J, Saeian K,. Recipient survival and graft survival are not diminished by simultaneous liver-kidney transplantation: an analysis of the united network for sharing database. Liver Transpl 2012; 18: 914-929.
24. Singh N, Gayowski T, Wagener MM,. Posttransplantation dialysis-associated infections: morbidity and impact on outcome in liver transplant recipients. Liver Transpl 2001; 7: 100-105.
25. Bellier C, Bert F, Durand F, Retout S, Belghiti J, Mentré F, Fantin B,. Risk factors for Enterobacteriaceae bacteremia after liver transplantation. Transpl Int 2008; 21: 755-763.
26. Immordino G, Bottino G, De Negri A, Diviacco P, Moraglia E, Ferrari C, et al., Predictability and survival in liver replantransplantation: monocentric experience. Transplant Proc 2014; 46: 2290-2292.
27. Morise Z, Kawabe N, Tomishige H, Nagata H, Kawase J, Arakawa S, et al., Recent advances in the surgical treatment of hepatocellular carcinoma. World J Gastroenterol 2014; 20: 14,381-14,392.
28. Giamarellou H, Antoniadou A, Kanellakopoulou K,. Acinetobacter baumannii: a universal threat to public health? Int J Antimicrob Agents 2008; 32: 106-119.
29. Playford EG, Craig JC, Iredell JR,. Carbapenem-resistant Acinetobacter baumannii in intensive care unit patients: risk factors for acquisition, infection and their consequences. J Hosp Infect 2007; 65: 204-211.